Introduction
The term "heterogeneity" literally means the quality or state of being diverse in character or content.
From its literal meaning, heterogeneity may even be considered as the other side of evenness coin 60 or as a proxy of biodiversity. Nevertheless, much of the formal and quantitative studies of heterogeneity in ecology has been performed separately from diversity research. For example, in population ecology, traditionally the terms heterogeneity, aggregation, dispersion, patchiness can be used interchangeably, and all of which were often used to characterize the spatial distribution of biological population. For this reason, the terms spatial heterogeneity and spatial distribution are 65 often used interchangeably in population ecology; in the former, the spatial information is referred implicitly and, in the later, the spatial information is referred explicitly. Therefore, to avoid confusion, the terms spatial heterogeneity (aggregation, dispersion, patchiness, contagiousness) should be more accurate in ecology. Note that temporal heterogeneity can also be defined and measured. In the temporal context, temporal heterogeneity is essentially a proxy of (temporal) stability of population 70 or community (Ma 2015 , Oh et al. 2016 . In this study, our focus is spatial heterogeneity.
When the concept of heterogeneity is constrained by the spatial arrangement (distribution) or temporal (variation), its difference with diversity or evenness becomes clear. Obviously, traditional 75 diversity concept and its various metrics do not usually deal with spatial arrangement (e.g., Chao et al. 2014) . We are only aware of two exceptions for the lack of spatial information. One is the concept of beta-diversity, which implicitly consider spatial information but is obviously far less convenient in processing spatial information than the heterogeneity concept. Another exception is to do with the concept of dominance (Ma & Ellison 2018 , which is briefly discussed below. 80 Spatial heterogeneity is a fundamental property of any natural ecosystems including human microbiomes. The spatial distribution of microbes on or in our bodies certainly possesses far-reaching implications to our health and diseases. Space is not only the last, but also a critical frontier in human microbiome research. In ecology, two most important scales that the spatial 85 heterogeneity exhibits are the population and community. Of course, to display spatial heterogeneity, there must be at least two individuals in the ecosystem, which implies that heterogeneity is a group (cohort, population, community, etc) characteristic. Obviously, the concept of heterogeneity is also widely used in other fields of biology (e.g., genetic heterogeneity and landscape heterogeneity).
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Theoretically, the abundance and distribution of species are among the most fundamental themes of both theoretical population and community ecology. The concept of heterogeneity, especially the spatial heterogeneity, is one of the most successful characterizations of species distribution and abundance (Cohen & Meng 2015 , Cohen & Saitoh 2016 , Ma 2015 , Reuman et al. 2014 , 2017 Taylor 1984 , Taylor et al., 1983 , 1988 . Practically, being able to predict the heterogeneity scaling 95 (change) over space and/or time, and to understand how the scaling is influenced by environmental disturbances such as diseases is of critical significance.
At population scale, aggregation or dispersion are preferred terms and can be used interchangeably with heterogeneity. In population ecology, aggregation can be measured quantitatively with 100
Taylor's (1961) power law, which achieved a rare status of ecological law (Taylor 2019) as further explained below shortly. In community level or multi-species assembly context, we use the term to refer to the uneven or heterogeneous nature of species abundances among different species within a community and/or between communities. At community scale, community spatial heterogeneity can be quantitatively measured with Taylor's power law extensions (TPLEs), which were proposed 105 by Ma (2015) via extending Taylor's (1961) power law from population to community level. On the surface, it appears that the community heterogeneity can be considered as the other side of diversity (evenness) "coin." However, as explained previously, community spatial heterogeneity deals with spatial information, therefore it is necessary to reiterate that the two sides of the same coin may indeed possess different patterns. In other words, the heterogeneity analysis cannot be replaced by diversity 110 analysis, and the former can offer unique insights, which traditional diversity analysis may not.
In microbial ecology, the spatial distribution of microbes (whether it is the distribution of pathogens or symbionts within our body) is, by no means, less important than in the ecology of plants and animals in nature. The spatial distribution of microbes within our bodies or the intersubject 115 heterogeneity (differences) can influence the competition, coexistence, dispersal, and spread of microbes within or between our bodies, and should have far reaching significance to our healthy and diseases. In fact, the term "heterogeneity" has frequently occurred in the mission statements of both the HMP (Human Microbiome Project) and HMP2 or iHMP (integrative HMP) of US-NIH, referring to various aspects of the human microbiome from inter-subject heterogeneity in microbiome 120 composition to the heterogeneity in disease treatment response (HMP Consortium 2012, iHMP Consortium 2019), which highlighted the significance of the heterogeneity in human microbiome research. Nevertheless, methodological studies on the heterogeneity have been relatively rare and studies that explicitly measure the relationship between microbiome heterogeneity and diseases effects are still few. In the present study, we fill this gap by reanalyzing a big dataset of 16s-rRNA 125 metagenomic datasets of 25 MAD (microbiome associated diseases) studies collected from existing literature, which cover all five major human microbiome habitats (gut, oral, skin, lung and vaginal) and include the majority of the high-profile MADs such as IBD, obesity, diabetes, BV, and neuron-degenerative diseases, and therefore of wide representative of the field.
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Indeed, the heterogeneity of human microbiome is remarkable. For instance, it was found that no gut bacterial strains of moderate abundance (>0.5% of the microbial community) were shared among all individuals of human twins (Turnbaugh & Gordon 2009 , Miller et al. 2019 ). However, characterizing, quantifying and interpreting the heterogeneity of human microbiomes are rather challenging (HMP Consortium 2012 , iHMP Consortium 2019 . For another example, Falony et al. 135 (2016) collected 503 host factors possibly influencing human gut microbiome across nearly 4000 individuals, but interpreted merely 16.4% of the variation among individuals. Miller et al. (2019) suggested that two roadblocks are responsible for the lack of explicability to the heterogeneity of human microbiome. First, the analysis scale was usually limited to individual subjects (hosts).
Second, the microbial dispersal across individual hosts was often ignored. Directly supporting Miller 140 et al. (2019) arguments are rare but certainly exist. For example, Rothschild et al. (2018) revealed that whether subjects lived together or not was the strongest predictor of microbiome variance, indicating that transmission (among hosts and between hosts and their environment) could be a critical driver of microbiome heterogeneity. Taylor's power law, which achieved a rare status of classic laws in macrobial ecology (Taylor 2019) and was recently extended to community ecology 145 of microbes (Ma 2015 , Oh 2016 , offers a powerful tool to remove the roadblocks for better understanding the heterogeneity of human microbiomes because of its inherent connections with spatial distribution and dispersion (Taylor 1983 (Taylor , 1984 (Taylor , 2019 .
The objective of this study is therefore two-fold. First, we investigate the relationship between the 150 inter-subject heterogeneity and major human MADs, determining whether or not diseases have significant influences on the inter-subject heterogeneity by harnessing the power of TPLEs in measuring community spatial heterogeneity, as explained above. Second, we compare the relationship between the heterogeneity-disease relationship (HDR) explored in this study with an early meta-analysis by on the diversity-disease relationship (DDR), and further 155 explore the relationship between the two relationships (HDR & DDR) and their ecological interpretations. Similar studies on the spatial distribution (heterogeneity) of host, pathogen and their implications to the disease of plants and animals have been investigating routinely for decades, and their significance to plant pathology and husbandry diseases have been well recognized (Noe & Campbell 1985 , Real 1996 , Emry et al. 2011 . Therefore, the study we conduct in this article should 160 have rather important significance to the investigation, diagnosis and treatment of the human microbiome associated diseases, similar to the experience in the studies on the diseases of plants and animals.
Materials and Methods
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The 16s-rRNA datasets of the human microbiome associated diseases A brief description on the 16s-rRNA datasets from the 25 human MAD (microbiome associated disease) studies is provided in Table S1 of the online supplementary information (OSI). These datasets covered five major human microbiome habitats (gut, oral, skin, lung, and vaginal) as well as milk and semen fluids. They also included the majority of the most common human MADs such 170 as IBD, obesity, diabetes, periodontitis, cystic fibrosis, mastitis, bacterial vaginosis, Parkinson's disease, schizophrenia. Therefore, the datasets are rather representative to the field of MADs.
Conceptual comparisons between population and community heterogeneities
Methodologically, the study of heterogeneity is dependent on statistical variance and its relationship with statistical mean of species abundance, or the so-termed Taylor's power law (TPL) (Taylor 1961) 175 and its extensions (Ma 2015 , Oh 2016 ) as explained below. The variance-mean power law relationship can reveal certain important community characteristics and insights, which the entropy-based diversity measures fail to offer (Ma 2015 , Ma & Ellison 2018 .
To explain why TPL is one of the most effective tools to investigate the population spatial distribution 180 (heterogeneity), it is necessary to recognize that there are three fundamental spatial distribution patterns of any biological populations from microbes to humans; those are: uniform, random and aggregated. The uniform distribution (sensu biologically) means that individuals of population in space are distributed with equal space and the distribution (pattern) can be described with the uniform distribution (sensu statistically). The random distribution means that individuals of population in 185 space are distributed randomly (not necessary with equal space distance) and can be described with Poisson statistical distribution. The aggregated distribution (also known as patchy, clumped, contagious, distribution) means that individuals in space are distributed far from random and often in clusters of different sizes. The statistical distribution for the aggregated or heterogeneous spatial distribution are usually rather special, and often follow highly skewed long-tail distributions such as 190 negative binomial, Ades distribution, power law distribution, or log-normal distribution (Perry & Taylor 1985) . Indeed, fitting statistical distributions to population abundance frequency is one of the three major approaches for investigating the spatial distribution (aggregation, heterogeneity, or pattern) of biological populations. The second approach to investigate the spatial heterogeneity is the so-termed aggregation (heterogeneity) index approach. In plant ecology, the spatial information is 195 explicit in the form of neighbor distances between plant individuals in a plot (Greg-Smith 1964) . In animal and insect ecology, neighbor-distance information is not often convenient to process, but the metrics and models for measuring aggregation/dispersion/heterogeneity still implicitly deal with spatial information. Various aggregation (heterogeneity) indexes were proposed to measure the aggregation (heterogeneity) levels of the spatial distribution of biological populations. The third 200 approach is the so-termed regression modeling, including two regression models. One is Iwao's (1968 Iwao's ( , 1977 the heterogeneity of a single population, just as the second approach. Although it contains more detailed information on the spatial heterogeneity than the second approach, it also suffers from the same disadvantage as the aggregation index approach.
At the community level, community spatial heterogeneity (CSH) can be similarly defined with the 215 population spatial heterogeneity (aggregation) (PSH) and investigated with similar approaches.
Fitting the species abundance distribution (SAD) such as lognormal and log-series distributions can be considered as the counterpart of the first approach (distribution-fitting to population abundances) in population ecology. The community dominance defined by Ma & Ellison (2018 , which extended Lloyd (1967) mean crowding concept, can be considered as the counterpart of the second 220 approach (aggregation index approach) in population ecology. The four TPL extensions (TPLEs) offer the third approach for investigating the community spatial heterogeneity (Ma 2015 , Oh 2016 , the counterpart of the third approach (TPL) in population ecology. In the present study, we apply the TPLEs for investigating the spatial heterogeneity of the human microbiomes as well as the influences of the microbiome-associated diseases on the heterogeneity. 225
Taylor's power law extensions (TPLEs)
Taylor (1961, 1984) revealed that the population mean (m) and variance (V) of a biological species in space follows power function,
where m is the mean population abundance of the species at a specific spatial site, V is the 230 corresponding variance, b is a species-specific parameter that measures the population aggregation (heterogeneity) degree, and a is a parameter primarily influenced by sampling scheme and is of relatively little biological significance. Eqn. (1), known as Taylor's power law (TPL) in literature, has been verified by numerous field investigations and theoretical analyses and it is considered one of few ecological laws in population ecology (Taylor 2019). 235 Ma (2015) extended the original TPL from single species population level to community level and introduced four power law extensions (TPLEs). Type-I TPLE was defined to quantify the community spatial heterogeneity, and it has the same mathematical form with the original TPL, but with different ecological interpretations, i.e., 240
where m i is the mean species abundance of all species in the i-th community (individual host subject) sampled, i.e., the mean population size (abundance) per species in the community, V i is the corresponding variance, N is the number of total communities (individual subjects) sampled, a is similarly interpreted as in the original TPL. 245
The parameter b of Type-I TPLE is a measure for the degree (level) of the community spatial heterogeneity (CSH). The CSH measures the dispersion (difference) in species abundances within a community as well as the scaling of the dispersion (difference) across space (i.e., across communities or sampled individual subjects). The larger the b-value is, the higher the community 250 heterogeneity is (Ma 2015 ). In the present study, we test whether or not the heterogeneity scaling parameter (b) can be significantly influenced by MADs.
Type-III TPLE was defined to assess the spatial heterogeneity of the mixed-species population, with the following formula, which is exactly the same with the original TPL and Type-I TPLE, just with 255 different ecological interpretations:
where m j is the mean population abundance of a specific species across all communities (individual subjects) sampled, V m is the corresponding variance, S is the number of species in the communities, a is sampling scheme related, and b measures the spatial heterogeneity of mixed-species. 260
The concept of mixed species was first discussed by Taylor et al. (1983) , and it synthesizes species-level spatial heterogeneity across all species. Type-III TPLE for mixed-species spatial heterogeneity synthesizes the dispersion (difference) in population abundance of a single species across space as well as the scaling of the dispersion (difference) across all species. The resultant 265 parameter b measures the heterogeneity (aggregation) characteristic of a virtually mixed species, assuming that species identity is irrelevant and can be ignored (Ma 2015 .
We use the log-linear transformations of TPLEs (2-3) to fit them statistically, i.e., € ln(V ) = ln(a) + bln(m).
(4) 270
As a side note, Type-II and Type-IV TPLEs were defined to quantify the temporal stability (heterogeneity), but they are not implicated in this study. Ma (2015) proposed the concept of community heterogeneity critical abundance (CHCA), which was defined with the following formula: 275
where a and b are the parameters of TPLE [eqns. (2-3) ]. CHCA is a threshold or transition point between the heterogeneous community and regular (completely even) community. At CHCA, the distribution of community heterogeneity should be random. The CHCA is an extension of Ma (1991) population aggregation critical density (PACD) to community scale. 280
Randomization tests for the influence of MADs on the spatial heterogeneity
The randomization (permutation) test is performed to determine whether or not the human microbiome associated disease (MADs) possesses statistically significant influences on the scaling (changes) of the spatial heterogeneity. The general procedure for randomization test is referred to Collingridge (2013) , and we adapted the general procedure for our testing the TPLE parameters as 285 following five steps. The number of re-samplings for randomization test is set to 1000 times to calculate the p-value for determining the significance of differences. The randomization test algorithm used to determine the differences in TPLE scaling parameters is exactly the same as that used in .
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Results
We fitted Type-I & Type-III TPLE models to the healthy (H) and diseased (D) treatments for each of the 25 MAD studies, respectively. Detailed fitting results were listed in Table S2 (for Type-I TPLE   or TPLE-I model) and Table S3 (for Type-III TPLE or TPLE-III model) . Fig 1 and Fig 2 illustrated the fittings of Type-I and Type-III TPLE models, respectively. The green lines and points 295 represent for the H treatments and the red (and blue) for the D treatments.
Suggested Location for Fig 1 Suggested Location for Fig 2
We further performed randomization (permutation) tests to detect the differences in the community 300 spatial heterogeneity (CSH) parameter (b) and ln(a) between the H and D treatments (Table S4 ). The community spatial heterogeneity parameter (b) (of TPLE-I) and the mixed-species population aggregation parameter (b) (of TPLE-III) were plotted in Fig 3. Fig 3 also marked the cases with significant differences in b between the H & D treatments, which were also displayed in Table   S4 (marked with grey shading). 305
Suggested Location for Fig 3
From Table S2 -S4, Figs 1-3 , we summarize the following four findings:
(i) All but one treatment in the 25 MAD studies were fitted to Type-I & III TPLE models successfully 310 (p<0.05). The only exception (the H treatment of case #1) exhibited a p-value of 0.067, which is not too far from the significance level (p=0.05) for determining the model fitting. (iii) Through the randomization tests for the differences in the heterogeneity parameter (b) between 320 the H & D treatments, it was found that: Type-I TPLE (for measuring the community spatial heterogeneity) parameter b is different in 10% of the MAD studies; Type-III TPLE parameter b (for measuring mix-species population aggregation) is different in approximately 12.5% of the MAD studies.
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(iv) Through the randomization tests for the differences in the TPLE parameter (a) between the H & D treatments, it was found that: Type-I TPLE parameter a is different in 12.5% of the MAD studies;
Type-III TPLE parameter a is different in approximately 17.5% of the MAD studies. This and the previous findings suggest that MADs appear to have a more far-reaching influence at the mixed-species level than at the community level. 330
Discussion
In the below, we further discuss the implications of the four findings, illustrated above, from the perspective of the heterogeneity-disease relationship (HDR). Our discussion is approached from comparison with our previous diversity-disease relationship (DDR) study . 335
First, the findings from the above HDR analysis echoed the conclusions from our previous DDR study ). In the previous study, the diversity in the Hill numbers (Chao et al. 2014) exhibited significant differences between the H & D in only approximately 1/3 of the MAD cases, and here the percentage from HDR analysis ranged between 10%-12.5%, which is less than ½ of the 340 percentage with difference from previous DDR analysis. This suggests that the MADs as disturbances on the human microbiomes can only exert limited influences on the community heterogeneity and/or diversity scaling (changes), and the influences on the heterogeneity appear to be less than on the diversity. In other words, the human microbiome ecosystem possesses significant stability (resilience). 345
However, in terms of the individual MAD case, the congruency between previous DDR analysis and HDR analysis in this study may or may not be aligned with each other. In the case of TPLE-I, there are two case studies (#14 & #18), which show significant disease effects in HDR analysis and also exhibited significant diseases effects in previous DDR analysis (Ma et al. 2019). 350 However, there are two case studies (#12 & #17) that show significant disease effects in HDR analysis but exhibited no significant disease effects in previous DDR analysis ). In the case of TPLE-III, the congruency between previous DDR analysis and HDR analysis in this study is aligned fully with each other indeed. All four MAD studies (#2, #4, #15 & #16) that exhibit significant disease effects in the HDR also showed significant disease effects in previous DDR 355 analysis .
Second, as to the reason why HDR analysis reveals a less significant percentage of differences (disease effects) than previous DDR analysis, the answer can be found by distinguishing the nature of the diversity metrics (Hill numbers) and the TPLE model (heterogeneity parameter b). What DDR 360 analysis reflects are primarily the ecological characteristics. In contrast, what HDR analysis, particularly Type-I TPLE, reflects are primarily the evolutionary characteristics. That is, the parameter (b) of TPLE is an evolutionary characteristic, which is well documented in existing literature (Taylor 1961 , 1980 , 1981 , 1984 , 1986a , 1986b , Taylor & Taylor 1977 , Taylor et al. 1983 , 1988 . Although, especially for microbes, the evolutionary and ecological characteristics are 365 often interwoven with each other and a clear division is usually difficult, the evolutionary properties should be more robust (stable) in general. This explains the relatively lower disease effects on the heterogeneity than on the diversity because the heterogeneity as evolutionary property should be more robust (stable).
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Third, as to the reason why TPLE heterogeneity parameter (b) showed a less significant percentage of differences (disease effects) than the other TPLE parameter (a) in detecting the MAD effects, the answer also lies in the fact that parameter (a) is not an evolutionary characteristic, instead, a is primarily influenced by sampling schemes (Taylor 1961 (Taylor , 1984 (Taylor , 1986a (Taylor , 1986b (Taylor , 2019 . For this reason, parameter (a) is often attached less importance or even ignored in literature. 375
Finally, as to the reason why Type-III TPLE or the TPLE for mixed-species population aggregation showed a more significant percentage of disease effects than Type-I TPLE, the answer lies in the fact that Type-III TPLE is essentially still a population level model, although it uses community level data. This finding also mirrored the results from shared species analysis in our previous study (Ma 380 et al. 2019) . The shared species analysis in that study revealed that in approximately 50% of the MAD cases, the shared species between the H & D samples were reduced due to the disease effects. In other words, the disease effects are more significant at species scale than at community scale. Online Supplementary Tables   Table S1 . Twenty-six 16S-rRNA metagenomic datasets utilized to analyze the effects of microbiome-associated diseases (MADs) on the microbiome heterogeneity 530 Table S2 . The parameters of Type-I power law extension (TPLE-I) for the community spatial heterogeneity for each H (healthy) or D (diseased) treatment of the 25 MAD studies Table S3 . The parameters of Type-III power law extension (TPLE-III) for mixed-species population spatial aggregation for each H (healthy) or D (diseased) treatment of the 25 MAD studies 535 Table S4 . The p-values from the permutation tests (with 1000 times of permutation re-sampling) for the differences in the TPLE-I and TPLE-III parameter (b) between the H and D treatments
